Legal Opinion
Cephalon, Inc. v. Watson Pharmaceuticals, Inc.
District Court, D. Delaware
Decided April 3, 2009No. Civ. 08-330-SLRPublishedCited by 32 opinions
1Opinion of the Court
MEMORANDUM OPINION
SUE L. ROBINSON, District Judge.
I. INTRODUCTION
On June 2, 2008, plaintiffs Cephalon, Inc. (“Cephalon”), and CIMA LABS, Inc. (“CIMA”), brought this suit against defendants Watson Pharmaceuticals, Inc. (“Pharmaceuticals”), and Watson Laboratories, Inc. (“Laboratories”), for infringement and declaratory judgment of infringement of United States Patent Nos. 6,200,604 B1 (“the '604 patent”) and 6,974,-590 B2 (“the '590 patent”) (D.I. 1) On January 16, 2009, plaintiffs amended their complaint to, inter alia, add Watson Pharma, Inc. (“Pharma”) as a defendant (D.I. 75). The suit…
2Cases cited48 opinions
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Erickson v. PardusSupreme Court of the United States · 2007
- Burger King Corp. v. RudzewiczSupreme Court of the United States · 1985
- Steel Co. v. Citizens for a Better EnvironmentSupreme Court of the United States · 1998
- World-Wide Volkswagen Corp. v. WoodsonSupreme Court of the United States · 1980
43 more not listed; retrieve them via the Exa API.
3Cited by32 opinions
- AstraZeneca UK Ltd. v. Aurobindo Pharma Ltd.Court of Appeals for the Federal Circuit · 2012
- Galderma Labs., L.P. v. Teva Pharm. USA, Inc.District Court, N.D. Texas · 2017
- Valeant Pharmaceuticals v. Mylan PharmaceuticalsCourt of Appeals for the Federal Circuit · 2020
- Robert Bosch LLC v. Alberee Products, Inc.District Court, D. Delaware · 2014
- In Re Cyclobenzaprine Hydrochloride Extended-Release Capsule Patent LitigationDistrict Court, D. Delaware · 2010
27 more not listed; retrieve them via the Exa API.